Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of PathologyReferences
- Cancer statistics, 2020.CA Cancer J Clin. 2020; 70: 7-30
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin. 2021; 71: 209-249
- Hereditary colorectal cancer.N Engl J Med. 2003; 348: 919-932
- Genetic alterations during colorectal-tumor development.N Engl J Med. 1988; 319: 525-532
- Wnt/beta-catenin signaling, disease, and emerging therapeutic modalities.Cell. 2017; 169: 985-999
- The Wnt signaling pathway: a potential therapeutic target against cancer.Ann N Y Acad Sci. 2019; 1443: 54-74
- Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond beta-catenin and the destruction complex.Exp Mol Med. 2020; 52: 183-191
- Can we safely target the WNT pathway?.Nat Rev Drug Discov. 2014; 13: 513-532
- Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors.Cancer Treat Rev. 2018; 62: 50-60
- Targeting Wnt signaling for gastrointestinal cancer therapy: present and evolving views.Cancers (Basel). 2020; 12: 3638
- Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma.Proc Natl Acad Sci U S A. 2012; 109: 4503-4508
- The transcription factor LSF: a novel oncogene for hepatocellular carcinoma.Am J Cancer Res. 2012; 2: 269-285
- Small molecule inhibitors of late SV40 factor (LSF) abrogate hepatocellular carcinoma (HCC): evaluation using an endogenous HCC model.Oncotarget. 2015; 6: 26266-26277
- Transcription factor LSF-DNMT1 complex dissociation by FQI1 leads to aberrant DNA methylation and gene expression.Oncotarget. 2016; 7: 83627-83640
- Targeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes, resulting in cell death or senescence.BMC Cancer. 2020; 20: 552
- TFCP2 is required for YAP-dependent transcription to stimulate liver malignancy.Cell Rep. 2017; 21: 1227-1239
- LSF expression and its prognostic implication in colorectal cancer.Int J Clin Exp Pathol. 2014; 7: 6024-6031
- Transcription factor late SV40 factor (LSF) functions as an oncogene in hepatocellular carcinoma.Proc Natl Acad Sci U S A. 2010; 107: 8357-8362
- Expression of TSG101 protein and LSF transcription factor in HPV-positive cervical cancer cells.Oncol Lett. 2014; 7: 1409-1413
- TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer.Oncotarget. 2017; 8: 70538-70549
- TFCP2/TFCP2L1/UBP1 transcription factors in cancer.Cancer Lett. 2018; 420: 72-79
- Lineage-specific and ubiquitous biological roles of the mammalian transcription factor LSF.Gene. 2004; 343: 23-40
- Wnt signaling in cancer.Oncogene. 2017; 36: 1461-1473
- c-Cbl mediates the degradation of tumorigenic nuclear beta-catenin contributing to the heterogeneity in Wnt activity in colorectal tumors.Oncotarget. 2016; 7: 71136-71150
- c-Cbl targets PD-1 in immune cells for proteasomal degradation and modulates colorectal tumor growth.Sci Rep. 2019; 9: 20257
- c-Cbl expression correlates with human colorectal cancer survival and its Wnt/beta-catenin suppressor function is regulated by Tyr371 phosphorylation.Am J Pathol. 2018; 188: 1921-1933
- Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL.Nat Cell Biol. 2008; 10: 1208-1216
- c-Cbl, a ubiquitin E3 ligase that targets active β-catenin: a novel layer of Wnt signaling regulation.J Biol Chem. 2013; 288: 23505-23517
- Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk.Sci Transl Med. 2017; 9: 1-11
- Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor-tissue factor axis.Blood. 2019; 134: 2399-2413
- Wnt signaling in disease and in development.Cell Res. 2005; 15: 28-32
- Comprehensive analysis of beta-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/beta-catenin signaling.BMC Genomics. 2014; 15: 74
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.Nature. 2009; 461: 614-620
- SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes.J Cell Biol. 2004; 166: 37-47
- The microtubule-associated histone methyltransferase SET8, facilitated by transcription factor LSF, methylates alpha-tubulin.J Biol Chem. 2020; 295: 4748-4759
- The many faces and functions of beta-catenin.EMBO J. 2012; 31: 2714-2736
- The sox family of transcription factors: versatile regulators of stem and progenitor cell fate.Cell Stem Cell. 2013; 12: 15-30
Article Info
Publication History
Publication stage
In Press Journal Pre-ProofFootnotes
Supported in part by NIH R01HL132325 and R21 DK119740 ; American Heart Association CAT-HD Center grant 857078 (V.C.C. and S.L.); an Ignition Award from the Office of Technology at Boston University (S.E.S., V.C.C., and U.H.); and Shepherd Therapeutics .
S.L. and D.L. share equal authorship.
Disclosures: S.E.S. and U.H. are cofounders of Lamerigen, Inc. S.E.S., E.A.Y., and U.H. received financial support from Shepherd Therapeutics. The remaining authors have no conflicts of interest.